These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22697612)

  • 1. Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.
    Derbala MF; Amer AM; Almohanadi M; John A; Amin A; John A; Sharma M; Alkaabi SR; Al Dweik NZ; Pasic F; Yaqoob R; Butt MT; Shebl FM
    J Viral Hepat; 2011 Jul; 18(7):e258-62. PubMed ID: 21108700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
    Fontana RJ; Dienstag JL; Bonkovsky HL; Sterling RK; Naishadham D; Goodman ZD; Lok AS; Wright EC; Su GL;
    Gut; 2010 Oct; 59(10):1401-9. PubMed ID: 20675691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries.
    Qian X; Zheng S; Wang L; Yao M; Guan G; Wen X; Zhang L; Xu Q; Chen X; Zhao J; Duan Z; Lu F
    Dis Markers; 2019; 2019():3862024. PubMed ID: 31636735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection.
    Gorin JB; Malone DFG; Strunz B; Carlsson T; Aleman S; Björkström NK; Falconer K; Sandberg JK
    Sci Rep; 2020 Feb; 10(1):2081. PubMed ID: 32034167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.
    Kuno A; Ikehara Y; Tanaka Y; Ito K; Matsuda A; Sekiya S; Hige S; Sakamoto M; Kage M; Mizokami M; Narimatsu H
    Sci Rep; 2013; 3():1065. PubMed ID: 23323209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic pathological features in naïve patients with chronic hepatitis C who have developed thyroid disorder.
    Biciuşcă V; Popescu M; Petrescu IO; Stan IS; Durand P; Petrescu M; Velea R; Traşcă DM; Popescu IAS; Udriştoiu I; Mărginean CM; Tudoraşcu DR; Petrescu F
    Rom J Morphol Embryol; 2020; 61(4):1085-1097. PubMed ID: 34171058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways.
    Ferrasi AC; Lima SVG; Galvani AF; Delafiori J; Dias-Audibert FL; Catharino RR; Silva GF; Praxedes RR; Santos DB; Almeida DTM; Lima EO
    World J Hepatol; 2023 Nov; 15(11):1237-1249. PubMed ID: 38075010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients.
    Sadek A; Abd El Hady AM; Olfat H; Abd El Hady AA; Wafy W; Zaki M; Youness ER
    J Complement Integr Med; 2024 Mar; 21(1):131-138. PubMed ID: 38190482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways.
    Quarleri J; Delpino MV
    World J Hepatol; 2023 Nov; 15(11):1170-1173. PubMed ID: 38075008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome genes polymorphisms may influence the development of hepatitis C in the Amazonas, Brazil.
    Toro DM; Ramasawmy R; Silva Neto PV; Pereira GL; Sarmento PS; Dray HLSN; Sousa KS; Affonso JS; Silva JA; Garcia NP; Barbieri MV; Victória FS; Donadi EA; Costa AG; Ogusku MM; Sadahiro A; Tarragô AM; Malheiro A
    PLoS One; 2021; 16(6):e0253470. PubMed ID: 34161370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years.
    Yoo JJ; Seo YS; Kim YS; Jeong SW; Jang JY; Suh SJ; Yim HJ; Suk KT; Kim DJ; Han KH; Kim SU; Lee B; Kim SG
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31771253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasome Genes' Polymorphisms in Egyptian Chronic Hepatitis C Patients: Influence on Vulnerability to Infection and Response to Treatment.
    Estfanous SZK; Ali SA; Seif SM; Soror SHA; Abdelaziz DHA
    Mediators Inflamm; 2019; 2019():3273645. PubMed ID: 30728751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection.
    Fischer J; Böhm S; Müller T; Witt H; Sarrazin C; Susser S; Migaud P; Schott E; Stewart G; Brodzinski A; Fülöp B; van Bömmel F; George J; Berg T
    PLoS One; 2013; 8(10):e77530. PubMed ID: 24204859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study.
    Mirza S; Siddiqui AR; Hamid S; Umar M; Bashir S
    BMC Gastroenterol; 2012 Jun; 12():71. PubMed ID: 22697612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
    Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
    J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients.
    Kim YJ; Jang BK; Kim ES; Park KS; Cho KB; Chung WJ; Hwang JS
    Korean J Hepatol; 2012 Mar; 18(1):41-7. PubMed ID: 22511902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C].
    Pár A
    Orv Hetil; 2002 Dec; 143(48):2667-74. PubMed ID: 12501575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of liver biopsy in the era of direct-acting antivirals.
    Gonzalez HC; Jafri SM; Gordon SC
    Curr Gastroenterol Rep; 2013 Feb; 15(2):307. PubMed ID: 23319086
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.